<PAGE> 1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON AUGUST 12, 1998
Registration No. 333-59053
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-2
---------------
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
---------------
SHAMAN PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
---------------
DELAWARE 94-3095806
(STATE OR OTHER JURISDICTION OF (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NUMBER)
213 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CALIFORNIA 94080
(650) 952-7070
(Address, including zip code, and telephone number,
including area code, of the Registrant's principal executive offices)
LISA A. CONTE
PRESIDENT AND CHIEF EXECUTIVE OFFICER
SHAMAN PHARMACEUTICALS, INC.
213 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CALIFORNIA 94080
(650) 952-7070
(Name, address, including zip code, and telephone number,
including area code, of agent for service of process)
Copies to:
<TABLE>
<S> <C>
J. STEPHEN DOLEZALEK, ESQ. A. JOHN MURPHY, ESQ.
BROBECK, PHLEGER & HARRISON LLP SHEPPARD, MULLIN, RICHTER & HAMPTON LLP
TWO EMBARCADERO PLACE, 2200 GENG ROAD SEVENTEENTH FLOOR, FOUR EMBARCADERO CENTER
PALO ALTO, CALIFORNIA 94301 SAN FRANCISCO, CALIFORNIA 94111-4106
(650) 424-0160 (415) 434-9100
</TABLE>
<PAGE> 2
SHAMAN PHARMACEUTICALS, INC.
This Registration Statement, as amended to the date of its effectiveness
(July 31, 1998), registered a minimum of 150,000 shares to a maximum of 200,000
Shares of the Series C Convertible Preferred Stock (the "Shares") of Shaman
Pharmaceuticals, Inc. (the "Registrant"). The Registrant sold none of the Shares
to the Investors. The offering has now been terminated. Accordingly, the
Registrant hereby deregisters the Shares originally covered by the Registration
Statement.
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
has duly caused this Post-Effective Amendment No. 1 to the Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of South San Francisco, State of California on this 12th
day of August, 1998.
SHAMAN PHARMACEUTICALS, INC.
By /s/ Lisa A. Conte
-------------------------------------
Lisa A. Conte
President and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this
Amendment No. 1 to the Registration Statement has been signed below by the
persons whose signatures appear below, which persons have signed such
Registration Statement in the capacities and on the dates indicated:
<TABLE>
<CAPTION>
NAME TITLE DATE
---- ----- ----
<S> <C> <C>
/s/ Lisa A. Conte Director, President, and Chief Executive Officer August 12, 1998
- ------------------------------------- (Principal Executive Officer)
Lisa A. Conte
* Chief Financial Officer (Chief Financial and August 12, 1998
- ------------------------------------- Accounting Officer)
Stephanie C. Diaz
* Chairman of the Board August 12, 1998
- -------------------------------------
G. Kirk Raab
- ------------------------------------- Director August __, 1998
Adrian D.P. Bellamy
- ------------------------------------- Director August __, 1998
Jeffrey Berg
* Director August 12, 1998
- -------------------------------------
Herbert H. McDade, Jr.
* Director August 12, 1998
- -------------------------------------
M. David Titus
By: /s/ Lisa A. Conte
---------------------------------
Lisa A. Conte,
(Attorney-in-Fact)
</TABLE>
3
